Every material Form 8-K AIRGAIN INC has filed with the SEC since May 06, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Airgain's board appointed Stephan D. Memmen as a Class II director, effective October 1, 2026, with a term expiring at the 2027 annual meeting. The board also increased its size from seven to eight directors, and the filing describes Mr. Memmen as independent under Nasdaq rules.
Stephan D. Memmen, 56, appointed to the board effective October 1, 2026, with a term ending at the 2027 annual meeting
Director award of restricted stock units and options, each valued at $50,000, vesting in three annual installments
Board size increased from seven to eight directors; filing says Mr. Memmen is independent under Nasdaq rules
Airgain reported second quarter 2026 results for the period ended June 30, 2026, with sales of $13.7 million, up 19.1% from $11.5 million in the first quarter but flat with $13.6 million a year earlier. The GAAP net loss was $1.7 million, or $(0.13) per share, narrowing from $1.9 million in the first quarter but slightly wider than the $(0.12) per share loss a year earlier. The company expects third quarter sales of $14.25 million to $16.25 million.
Q2 2026 sales were $13.7 million, up $2.2 million or 19.1% from Q1 2026 and up 0.7% from Q2 2025.
GAAP net loss was $1.7 million, or $(0.13) per share; non-GAAP net income was $0.3 million, or $0.02 per share.
Adjusted EBITDA was $0.4 million, compared with $(0.9) million in Q1 2026.
Third quarter 2026 outlook: sales of $14.25 million to $16.25 million and GAAP net loss of $(0.03) per share at the midpoint.
Airgain reported first-quarter 2026 sales of $11.5 million, down from $12.0 million a year earlier, and a GAAP net loss of $1.9 million, or $(0.15) per share, compared with a $1.5 million loss a year earlier. The company also guided to second-quarter 2026 sales of $12.5 million to $14.5 million and a GAAP net loss of $(0.07) per share at the midpoint.
Q1 2026 sales were $11.5 million, down 4.2% from $12.0 million in Q1 2025 and down from $12.1 million in Q4 2025.
GAAP net loss was $1.9 million, or $(0.15) per share, versus $1.5 million, or $(0.13) per share, in Q1 2025.
Non-GAAP net loss was $1.0 million, or $(0.08) per share, compared with $1.3 million, or $(0.11) per share, a year earlier.
Q2 2026 outlook: sales of $12.5 million to $14.5 million and GAAP net loss per share of $(0.07) at the midpoint.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every AIRGAIN INC filing is on SEC EDGAR ↗. 8-K briefs of other companies →